Human iPS cells made available to companies and universities
The company iPS Academia, manager of intellectual property rights of induced pluripotent stem cells (or iPS), concluded its first license agreements with two biotechnology companies, and Reprocell Inc. Takara Bio.
The team of Professor Yamanaka of Kyoto University, has established a process for producing pluripotent stem cells – i.e., able to [...]

